RxDoctor Payments Data

Brent Earls, MD

Pain Medicine · Washington, DCNPI 1104280957

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.1%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medtronic at 44.4% of the total. Reporting peaked in 2020 at $3,271 and has fallen 98.4% since, to $53 in 2025.

$7,202in general payments, 2019–2025

Across 119 payments — averaging $60.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Abbott$1K
  • Nevro Corp.$702
  • Saluda Medical Americas, Inc.$448
  • Vertos Medical, Inc.$363
  • Boston Scientific$238
  • plus $973 from 17 others

What the payments were for

  • Grants$3,00042%
  • Travel & lodging$4897%
  • Food & beverage$3,67851%
  • Education$350%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pain medicine providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$229,650
Medicare patients
392
Services billed
1,379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine18$4,850
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen204$4,370
Duloxetine Hcl69$1,915
Gabapentin121$1,753
Oxycodone Hcl107$1,747
Pregabalin72$1,649
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$1,386
Diclofenac Sodium33$858
Methadone Hcl72$652
Cyclobenzaprine Hcl58$541
Nortriptyline Hcl13$321
Tramadol Hcl54$260
Acetaminophen-CodeineAcetaminophen With Codeine21$240
Tizanidine Hcl18$215
Methocarbamol13$178

Paid to pharmacies, not to this prescriber.

Other pain medicine in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →